Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Shenzhen Chipscreen Biosciences Co stock price, quote, forecast and news

688321.SS
CNE100003LW0

Price

16.47
Today +/-
+0
Today %
+0 %
P

Shenzhen Chipscreen Biosciences Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Shenzhen Chipscreen Biosciences Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Shenzhen Chipscreen Biosciences Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Shenzhen Chipscreen Biosciences Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Shenzhen Chipscreen Biosciences Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Shenzhen Chipscreen Biosciences Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Shenzhen Chipscreen Biosciences Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Shenzhen Chipscreen Biosciences Co’s growth potential.

Shenzhen Chipscreen Biosciences Co Revenue, EBIT and net profit per share

DateShenzhen Chipscreen Biosciences Co RevenueShenzhen Chipscreen Biosciences Co EBITShenzhen Chipscreen Biosciences Co Net Income
2026e1.24 B undefined34.34 M undefined12.27 M undefined
2025e947.38 M undefined-58.58 M undefined-81.82 M undefined
2024e712.05 M undefined-157.56 M undefined-159.55 M undefined
2023523.71 M undefined-169.07 M undefined88.84 M undefined
2022529.94 M undefined16.62 M undefined17.48 M undefined
2021430.45 M undefined15.25 M undefined21.96 M undefined
2020269.5 M undefined20.8 M undefined31 M undefined
2019173.8 M undefined11.2 M undefined19.4 M undefined
2018147.7 M undefined28.2 M undefined31.2 M undefined
2017110.5 M undefined26.1 M undefined24.1 M undefined
201685.4 M undefined1.1 M undefined5.2 M undefined

Shenzhen Chipscreen Biosciences Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
201620172018201920202021202220232024e2025e2026e
0.090.110.150.170.270.430.530.520.710.951.24
-29.4133.6417.6955.4959.8523.02-1.1336.1433.0130.52
97.6595.4596.6095.9595.1794.8894.3389.10---
83105142166256408499466000
1262811201516-169-157-5834
1.1823.6419.056.367.433.493.02-32.31-22.05-6.122.75
524311931211788-159-8112
-380.0029.17-38.7163.16-32.26-19.05417.65-280.68-49.06-114.81
330348.7360376.4410409.67406.97411.29000
-----------
Details

Keystats

ⓘ

Revenue and Growth

The Shenzhen Chipscreen Biosciences Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Shenzhen Chipscreen Biosciences Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Shenzhen Chipscreen Biosciences Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Shenzhen Chipscreen Biosciences Co's financial health and stability.

Assets

Shenzhen Chipscreen Biosciences Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Shenzhen Chipscreen Biosciences Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Shenzhen Chipscreen Biosciences Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Shenzhen Chipscreen Biosciences Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2016201720182019202020212022
0000000
0000000
0000000
-37-53-90-153-207-229-456
0000000
0000000
-8-22-36-33-18-147
59222-249312443
-65-132-140-133-336-288-400
-135-196-13-721-108-30-801
-69-63127-588227257-401
0000000
46-21186-4284283
0000000
14119217950-45-63861
9821509450-143590
-3-20-1-3-4-12
17375178367255397606
-6.04-130.09-117.96-157.57-242.65-163.68-356.87
0000000

Shenzhen Chipscreen Biosciences Co stock margins

The Shenzhen Chipscreen Biosciences Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Shenzhen Chipscreen Biosciences Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Shenzhen Chipscreen Biosciences Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Shenzhen Chipscreen Biosciences Co's sales revenue. A higher gross margin percentage indicates that the Shenzhen Chipscreen Biosciences Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Shenzhen Chipscreen Biosciences Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Shenzhen Chipscreen Biosciences Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Shenzhen Chipscreen Biosciences Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Shenzhen Chipscreen Biosciences Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Shenzhen Chipscreen Biosciences Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Shenzhen Chipscreen Biosciences Co Margin History

Shenzhen Chipscreen Biosciences Co Gross marginShenzhen Chipscreen Biosciences Co Profit marginShenzhen Chipscreen Biosciences Co EBIT marginShenzhen Chipscreen Biosciences Co Profit margin
2026e89.12 %2.78 %0.99 %
2025e89.12 %-6.18 %-8.64 %
2024e89.12 %-22.13 %-22.41 %
202389.12 %-32.28 %16.96 %
202294.34 %3.14 %3.3 %
202194.99 %3.54 %5.1 %
202094.99 %7.72 %11.5 %
201995.8 %6.44 %11.16 %
201896.28 %19.09 %21.12 %
201795.2 %23.62 %21.81 %
201697.42 %1.29 %6.09 %

Shenzhen Chipscreen Biosciences Co Stock Sales Revenue, EBIT, Earnings per Share

The Shenzhen Chipscreen Biosciences Co earnings per share therefore indicates how much revenue Shenzhen Chipscreen Biosciences Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Shenzhen Chipscreen Biosciences Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Shenzhen Chipscreen Biosciences Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Shenzhen Chipscreen Biosciences Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Shenzhen Chipscreen Biosciences Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Shenzhen Chipscreen Biosciences Co Revenue, EBIT and net profit per share

DateShenzhen Chipscreen Biosciences Co Sales per ShareShenzhen Chipscreen Biosciences Co EBIT per shareShenzhen Chipscreen Biosciences Co Earnings per Share
2026e3.05 undefined0 undefined0.03 undefined
2025e2.34 undefined0 undefined-0.2 undefined
2024e1.76 undefined0 undefined-0.39 undefined
20231.27 undefined-0.41 undefined0.22 undefined
20221.3 undefined0.04 undefined0.04 undefined
20211.05 undefined0.04 undefined0.05 undefined
20200.66 undefined0.05 undefined0.08 undefined
20190.46 undefined0.03 undefined0.05 undefined
20180.41 undefined0.08 undefined0.09 undefined
20170.32 undefined0.07 undefined0.07 undefined
20160.26 undefined0 undefined0.02 undefined

Shenzhen Chipscreen Biosciences Co business model

Shenzhen Chipscreen Biosciences Co is one of the most popular companies on Eulerpool.com.

Shenzhen Chipscreen Biosciences Co historical P/E ratio, EBIT, and P/S ratio.

Shenzhen Chipscreen Biosciences Co shares outstanding

The number of shares was Shenzhen Chipscreen Biosciences Co in 2023 — This indicates how many shares 411.287 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Shenzhen Chipscreen Biosciences Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Shenzhen Chipscreen Biosciences Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Shenzhen Chipscreen Biosciences Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Shenzhen Chipscreen Biosciences Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Shenzhen Chipscreen Biosciences Co.

Eulerpool ESG Scorecard© for the Shenzhen Chipscreen Biosciences Co stock

Eulerpool World ESG Rating (EESG©)

47/ 100

🌱 Environment

47

👫 Social

66

🏛️ Governance

28

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
✅
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
✅
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees49
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement✅
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Shenzhen Chipscreen Biosciences Co list of shareholders

%
Name
Stocks
Change
Date
8.57 % CapitalBio Corporation34,705,162012/31/2023
5.66 % Shenzhen Haiyuemen Biological Technology Development Company Ltd.22,936,008012/31/2023
5.49 % Lu (Xian Ping)22,239,625012/31/2023
4.89 % Shenzhen Haide Ruibo Investment Company Ltd.19,817,445012/31/2023
3.74 % Shenzhen Haide Kangcheng Investment Partnership LP15,155,290012/31/2023
3.24 % Vertex Venture Holdings Ltd.13,125,918-48,80012/31/2023
2.90 % Nanchang Haide Ruiyuan Enterprise Management Partnership (LP)11,753,849012/31/2023
2.90 % Shenzhen Haide Ruida Enterprise Management Partnership (LP)11,753,849012/31/2023
2.32 % Shenzhen Haide Xincheng Enterprise Management Partnership (LP)9,416,540012/31/2023
2.03 % Tianfu Qingyuan Holdings Co., Ltd.8,214,410012/31/2023
1
2
3
4
5
...
9

Shenzhen Chipscreen Biosciences Co Executives and Management Board

Mr. Xianping Lu59
Shenzhen Chipscreen Biosciences Co Chairman of the Board, General Manager (since 2018)
Compensation 3.1 M
Mr. Desi Pan52
Shenzhen Chipscreen Biosciences Co Chief Scientific Officer, Deputy General Manager
Compensation 1.47 M
Mr. Libin Zhang50
Shenzhen Chipscreen Biosciences Co Deputy General Manager
Compensation 1.24 M
Mr. Zhibin Li58
Shenzhen Chipscreen Biosciences Co Deputy General Manager
Compensation 1.18 M
Mr. Jianxun Li52
Shenzhen Chipscreen Biosciences Co Finance Director, Deputy General Manager, Director (since 2018)
Compensation 1.17 M
1
2
3

Shenzhen Chipscreen Biosciences Co Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Shanghai Medicilon A Stock
Shanghai Medicilon A
SupplierCustomer0,790,580,310,640,60-0,48
Shanghai Pharm Hldg H Stock
Shanghai Pharm Hldg H
SupplierCustomer0,610,260,620,530,67-0,11
China Resources Sanjiu A Stock
China Resources Sanjiu A
SupplierCustomer0,530,04-0,13-0,66-0,83-0,37
China Resources Pharma Gr Stock
China Resources Pharma Gr
SupplierCustomer0,490,10-0,54-0,500,190,18
Innovent Biologics Stock
Innovent Biologics
SupplierCustomer-0,36-0,030,910,890,930,20
Sinopharm Group H Stock
Sinopharm Group H
SupplierCustomer-0,36-0,030,25-0,290,600,04
1

Most common questions regarding Shenzhen Chipscreen Biosciences Co

What is the P/E ratio of Shenzhen Chipscreen Biosciences Co 2024?

The Shenzhen Chipscreen Biosciences Co P/E ratio is -42.46.

What is the P/S ratio of Shenzhen Chipscreen Biosciences Co 2024?

The Shenzhen Chipscreen Biosciences Co P/S ratio is 9.51.

What is the AlleAktien quality score of Shenzhen Chipscreen Biosciences Co?

The AlleAktien quality score for Shenzhen Chipscreen Biosciences Co is 3/10.

What is the revenue of Shenzhen Chipscreen Biosciences Co 2024?

The expected Shenzhen Chipscreen Biosciences Co revenue is 712.05 M CNY.

How high is the profit of Shenzhen Chipscreen Biosciences Co 2024?

The expected Shenzhen Chipscreen Biosciences Co profit is -159.55 M CNY.

What is the business model of Shenzhen Chipscreen Biosciences Co

No history available for Shenzhen Chipscreen Biosciences Co.

What is the Shenzhen Chipscreen Biosciences Co dividend?

Shenzhen Chipscreen Biosciences Co pays a dividend of 0 CNY distributed over payouts per year.

How often does Shenzhen Chipscreen Biosciences Co pay dividends?

The dividend cannot currently be calculated for Shenzhen Chipscreen Biosciences Co or the company does not pay out a dividend.

What is the Shenzhen Chipscreen Biosciences Co ISIN?

The ISIN of Shenzhen Chipscreen Biosciences Co is CNE100003LW0.

What is the Shenzhen Chipscreen Biosciences Co ticker?

The ticker of Shenzhen Chipscreen Biosciences Co is 688321.SS.

How much dividend does Shenzhen Chipscreen Biosciences Co pay?

Over the past 12 months, Shenzhen Chipscreen Biosciences Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Shenzhen Chipscreen Biosciences Co is expected to pay a dividend of 0 CNY.

What is the dividend yield of Shenzhen Chipscreen Biosciences Co?

The current dividend yield of Shenzhen Chipscreen Biosciences Co is .

When does Shenzhen Chipscreen Biosciences Co pay dividends?

Shenzhen Chipscreen Biosciences Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Shenzhen Chipscreen Biosciences Co?

Shenzhen Chipscreen Biosciences Co paid dividends every year for the past 0 years.

What is the dividend of Shenzhen Chipscreen Biosciences Co?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Shenzhen Chipscreen Biosciences Co located?

Shenzhen Chipscreen Biosciences Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shenzhen Chipscreen Biosciences Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shenzhen Chipscreen Biosciences Co from 7/31/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 7/31/2024.

When did Shenzhen Chipscreen Biosciences Co pay the last dividend?

The last dividend was paid out on 7/31/2024.

What was the dividend of Shenzhen Chipscreen Biosciences Co in the year 2023?

In the year 2023, Shenzhen Chipscreen Biosciences Co distributed 0 CNY as dividends.

In which currency does Shenzhen Chipscreen Biosciences Co pay out the dividend?

The dividends of Shenzhen Chipscreen Biosciences Co are distributed in CNY.

All fundamentals about Shenzhen Chipscreen Biosciences Co

Our stock analysis for Shenzhen Chipscreen Biosciences Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shenzhen Chipscreen Biosciences Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.